Theratechnologies (TSE:TH) Shares Cross Above 50 Day Moving Average - What's Next?

Key Points

• Theratechnologies Inc. (TSE:TH) shares have crossed above their 50-day moving average of C$3.90, reaching a high of C$4.41 during trading.
• Despite this upward movement, Jones Trading downgraded the stock from a "strong-buy" to a "hold" rating on July 3rd.
• The company focuses on specialty pharmaceutical products for HIV patients, operating primarily in Canada and the United States, with two approved products: EGRIFTA and Trogarzo.

Shares of Theratechnologies Inc. (TSE:TH - Get Free Report) crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of C$3.90 and traded as high as C$4.41. Theratechnologies shares last traded at C$4.40, with a volume of 3,778 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Jones Trading lowered shares of Theratechnologies from a "strong-buy" rating to a "hold" rating in a research note on Thursday, July 3rd.

Theratechnologies Trading Up 0.2%

The company has a quick ratio of 0.64, a current ratio of 1.08 and a debt-to-equity ratio of -293.92. The business's 50 day moving average is C$3.92 and its 200-day moving average is C$3.22. The firm has a market cap of C$140.70 million, a P/E ratio of -49.92, a price-to-earnings-growth ratio of -8.50 and a beta of 1.73.

About Theratechnologies

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.